Home Home Home Inbox Home Search

Exhibitor

Actelion Pharmaceuticals US Inc.

Booth 2235

Description

"In June 2017, Actelion Ltd. became part of the Janssen Pharmaceutical Companies of Johnson & Johnson. The company is a leading biopharmaceutical company focused on the discovery, development, and commercialization of innovative drugs for diseases with significant unmet medical needs."

Categories

Company Info

Home Home Home Inbox Home Search